http://www.naturalnews.com/z023583.html


(NaturalNews) In the latest example of absurd disease mongering to receive widespread media attention, the American Academy of Pediatrics Committee has announced that infants as young as two years old need to be screened for high cholesterol, and children as young as eight years old should be put on prescription statin drugs. This absurd advice is being offered even though statin drugs have never been tested on children, nor approved by the FDA for use on children.

The point of all this? To sell more high-profit prescription drugs, of course, to yet another group of victims being targeted for medication by Big Pharma. This is called "market expansion," and it's the only way drug companies can continue to grow their profits and keep shareholders happy.

As drug companies continue to expand their profits and influence over the now-utterly-corrupt medical industry, they are also expanding their customer base by continuing to push medications for increasingly younger demographic groups. Not content to drug more than half the adults in western nations, Big Pharma now sees children as its next area of market growth, in much the same way that soda companies once sought to persuade parents to feed their babies soda pop as a way to instill the desire for sugary beverages at a very young age.